Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Peptide Bioregulator
Also known as Lys-Glu (KE)
Vilon is the dipeptide Lys-Glu, one of the most extensively studied short peptide bioregulators, examined in research on chromatin activation and immune endpoints.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Vilon is the dipeptide Lys-Glu, one of the most extensively studied short peptide bioregulators, examined in research on chromatin activation and immune endpoints.
Experimental models span lymphocyte cultures from older donors, gene-expression profiling, and tumour-induction studies in rodents.
Third-party tested for purity, ID, quantity.
Vilon is a two-residue peptide with an unusually broad literature for its size. Published work has reported reactivation of chromatin in cultured lymphocytes from older people, effects on gene expression in mouse heart characterized by DNA microarray, and modulation of gene expression in ageing mesenchymal stem cell cultures.
Separate research examined signal transduction along the sphingomyelin pathway in thymocytes, and the peptide appears throughout reviews of short-peptide epigenetic regulation.
Vilon was among the first synthetic short peptides characterized in the Russian bioregulator programme, developed as a defined analogue of thymic peptide preparations.
Work from the late 1990s onward established it as the reference compound for the class, frequently used as a comparator against Epitalon.
Research into the Lys-Glu dipeptide focuses on chromatin reactivation in ageing cells and on gene-expression regulation. Frameworks evaluate heterochromatin decondensation, microarray transcriptional profiles, sphingomyelin-pathway signaling, and immune endpoints under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Vilon. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Bioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people
PubMedStudies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology
PubMedEffects of short peptides on thymocyte blast transformation and signal transduction along the sphingomyelin pathway
PubMedGene expression in human mesenchymal stem cell aging cultures: modulation by short peptides
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$0.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
